Sleep

Researchers find that a patient with depressive symptoms and cognitive impairment who did not respond to prior antidepressant medication showed marked improvement through continuous positive airway pressure (CPAP) therapy after being diagnosed with underlying severe obstructive sleep apnea.

Patients with narcolepsy type 1 who are working or studying from home amid the coronavirus disease 2019 pandemic exhibited an increase in nocturnal sleep time and reduced daytime sleepiness. These patients also presented with significant weight gain.

Among patients with long-term usage of continuous positive airway pressure (CPAP) therapy, several mask-related adverse effects were associated with CPAP nonadherence and residual excessive sleepiness.

Obstructive sleep apnea was identified as an independent risk factor for severe coronavirus disease 2019 (COVID-19) resulting in hospitalization.

There is a greater prevalence of acid reflux disease in patients with both of these conditions, and treating the sleep apnea in turn may improve the acid reflux, which then may improve the cough, stated Krishna M. Sundar, MD, clinical professor, Pulmonary Division, Department of Medicine, and medical director, Sleep-Wake Center, University of Utah.

Among patients hospitalized with coronavirus disease 2019 (COVID-19) in Wuhan, China, fatigue and muscle weakness, as well as sleep difficulties, were shown to persist in more than 1 in 4 patients after 6 months.

Among patients who have chronic obstructive pulmonary disease (COPD), the pathophysiology for disturbed sleep consists of physiological changes, ventilatory disturbances, and inflammation.

In recent clinical practice guidelines issued by the American Academy of Sleep Medicine (AASM), authors established recommendations for the use of behavioral and psychological treatments for chronic insomnia disorder in adults.

The top 5 most-read sleep stories of 2020 on AJMC.com spotlighted the role of sleep hygiene among children and adolescents, changes in sleeping habits amid the pandemic, and how a rare gene mutation may cause people to require less sleep to achieve wakefulness.

Researchers discuss recent insights on the relationship between sleep-disordered breathing (SDB) and atrial fibrillation (AF), particularly how proper SDB management can reduce the incidence, burden, and recurrence of AF.

There are several signs characteristic of obstructive sleep apnea (OSA) in children and adolescents, but a sleep study interpreted according to pediatric standards is the only way to properly diagnose conditions such as sleep apnea, restless leg syndrome, or primary snoring in these populations.

Among patients with obstructive sleep apnea (OSA), the presence of anxiety was shown to have an inverse relationship with the severity of OSA, whereas symptoms of depression did not exhibit a similar relationship.

New devices can help to manage sleep apneas, but underlying conditions must be treated, too, noted Krishna M. Sundar, MD, clinical professor, Pulmonary Division, Department of Medicine, medical director, Sleep-Wake Center, University of Utah.

Among patients with obstructive sleep apnea (OSA), reduced dominant hand grip strength was found to correlate with lower oxygen nadir and increased apnea duration, with fat mass also consistently associated with worsening OSA indices.

Incidence and prevalence rates of narcolepsy were assessed in a meta-review of 30 countries, with a trend of underreporting found in ethnic/race and gender minorities, childhood narcolepsy type 2, and among patients with comorbid conditions.

Intermittent hypoxia sensitizes control centers in the brain, noted Krishna M. Sundar, MD, clinical professor, Pulmonary Division, Department of Medicine, and medical director, Sleep-Wake Center, University of Utah.

Teens with migraines attending high schools starting before 8:30 am were found to experience an average 7.7 headache days per month, nearly 3 more headache days than those with later school start times, according to study findings published today.

More than 1 in 4 patients with COVID-19 admitted to the hospital during the first wave of the pandemic in Finland were found to have obstructive sleep apnea, signaling a potential at-risk population.

Results from a phase 3 study of Xywav in adult patients with idiopathic hypersomnia exhibited its potential to address this unmet medical need.

Age, sex, and body mass index typically drive the development of obstructive sleep apnea, noted Krishna M. Sundar, MD, clinical professor, Pulmonary Division, Department of Medicine, medical director, Sleep-Wake Center, University of Utah.

Experts spotlighted sex- and gender-specific changes in normal sleep and sleep disturbance, as well as attributable risk factors, during a session at the CHEST 2020 annual meeting.

In collaboration with the American Heart Association, Jazz Pharmaceuticals will provide a wide variety of sleep health educational content, including scientific research, reading materials for both patients and practitioners, and podcasts from experts in the field speaking to the importance of sleep on cardiovascular health.

Amid the coronavirus disease 2019 pandemic, patients with narcolepsy reported changes in bedtime and waking schedules, as well as an increase in adverse symptoms such as cataplexy and sleep paralysis.

Much of the population experiences disordered breathing at night, explained Krishna M. Sundar, MD, clinical professor, Pulmonary Division, Department of Medicine, and medical director, Sleep-Wake Center, University of Utah.